Literature DB >> 19193883

Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues.

Tatiana Sorkina1, Toni L Richards, Anjali Rao, Nancy R Zahniser, Alexander Sorkin.   

Abstract

The plasma membrane dopamine transporter (DAT) takes extracellular dopamine back up into dopaminergic neurons. Although the number of DATs at the cell surface is regulated by endocytosis and recycling, the molecular mechanisms that control this endocytic trafficking of DAT are not defined. To map the sequence motifs that are involved in constitutive DAT endocytosis, mutagenesis of human DAT tagged with yellow fluorescent protein (YFP) and an extracellular HA epitope was performed. Removal of the entire N terminus of DAT resulted in accumulation of the resulting DAT mutant (YFP-HA-DeltaN-DAT) in early and recycling endosomes in HeLa and PAE cells, and in primary rat mesencephalic-striatal neuronal cocultures. This endosomal accumulation was due to rapid constitutive internalization of YFP-HA-DeltaN-DAT by the clathrin-dependent pathway. Small deletions and multialanine substitutions in the N terminus revealed two molecular determinants within the membrane proximal residues 60-65 that are important for preventing rapid internalization of DAT. First, mutations of Arg60 or Trp63, leading to disruption of the "outward facing" DAT conformation, correlated with an increased pool of mobile DATs in the plasma membrane and accelerated constitutive internalization of the DAT mutants. Second, mutation of Lys65 also correlated with elevated endocytosis. While none of these mutations alone recapitulated the marked endocytic phenotype of YFP-HA-DeltaN-DAT, simultaneous elimination of both the outward conformation of DAT and Lys65 resulted in DAT mutants that were rapidly internalized. Thus, our studies reveal a new link between DAT endocytosis and conformation-dependent uptake activity that represents a novel mode for regulating DAT function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193883      PMCID: PMC2745124          DOI: 10.1523/JNEUROSCI.3250-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.

Authors:  Anette M Hommelgaard; Mads Lerdrup; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

Review 2.  Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation.

Authors:  Haley E Melikian
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines.

Authors:  Merewyn K Loder; Haley E Melikian
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

4.  Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.

Authors:  G M Daniels; S G Amara
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

5.  Mobility measurement by analysis of fluorescence photobleaching recovery kinetics.

Authors:  D Axelrod; D E Koppel; J Schlessinger; E Elson; W W Webb
Journal:  Biophys J       Date:  1976-09       Impact factor: 4.033

6.  Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter.

Authors:  Gonzalo E Torres; Ana Carneiro; Katie Seamans; Chiara Fiorentini; Ava Sweeney; Wei-Dong Yao; Marc G Caron
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

7.  Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy.

Authors:  Tatiana Sorkina; Suzanne Doolen; Emilia Galperin; Nancy R Zahniser; Alexander Sorkin
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

Review 8.  Rapid regulation of the dopamine transporter: role in stimulant addiction?

Authors:  Nancy R Zahniser; Alexander Sorkin
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

9.  Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.

Authors:  Francesca Binda; Concetta Dipace; Erica Bowton; Sabrina D Robertson; Brandon J Lute; Jacob U Fog; Minjia Zhang; Namita Sen; Roger J Colbran; Margaret E Gnegy; Ulrik Gether; Jonathan A Javitch; Kevin Erreger; Aurelio Galli
Journal:  Mol Pharmacol       Date:  2008-07-10       Impact factor: 4.436

10.  N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.

Authors:  Habibeh Khoshbouei; Namita Sen; Bipasha Guptaroy; L 'Aurelle Johnson; David Lund; Margaret E Gnegy; Aurelio Galli; Jonathan A Javitch
Journal:  PLoS Biol       Date:  2004-03-16       Impact factor: 8.029

View more
  34 in total

1.  The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking.

Authors:  Deanna M Navaroli; Zachary H Stevens; Zeljko Uzelac; Luke Gabriel; Michael J King; Lawrence M Lifshitz; Harald H Sitte; Haley E Melikian
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.

Authors:  Anne Vuorenpää; Trine N Jørgensen; Amy H Newman; Kenneth L Madsen; Mika Scheinin; Ulrik Gether
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

3.  Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.

Authors:  Luke R Gabriel; Sijia Wu; Patrick Kearney; Karl D Bellvé; Clive Standley; Kevin E Fogarty; Haley E Melikian
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

4.  Dopamine transporter is enriched in filopodia and induces filopodia formation.

Authors:  John Caltagarone; Shiqi Ma; Alexander Sorkin
Journal:  Mol Cell Neurosci       Date:  2015-04-30       Impact factor: 4.314

5.  Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons.

Authors:  Anjali Rao; Toni L Richards; Diana Simmons; Nancy R Zahniser; Alexander Sorkin
Journal:  FASEB J       Date:  2012-01-20       Impact factor: 5.191

6.  Enhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression.

Authors:  XinJian Liu; Qian Huang; Fang Li; Chuan-Yuan Li
Journal:  Sci China Life Sci       Date:  2014-08-16       Impact factor: 6.038

7.  Dopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities.

Authors:  Carolyn G Sweeney; Bradford P Tremblay; Thomas Stockner; Harald H Sitte; Haley E Melikian
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

8.  Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons.

Authors:  Anjali Rao; Diana Simmons; Alexander Sorkin
Journal:  Mol Cell Neurosci       Date:  2010-09-15       Impact factor: 4.314

9.  Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact.

Authors:  Rita R Fagan; Patrick J Kearney; Carolyn G Sweeney; Dino Luethi; Florianne E Schoot Uiterkamp; Klaus Schicker; Brian S Alejandro; Lauren C O'Connor; Harald H Sitte; Haley E Melikian
Journal:  J Biol Chem       Date:  2020-03-04       Impact factor: 5.157

10.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.